Stephen P. Ewald - 29 Oct 2026 Form 4 Insider Report for Medpace Holdings, Inc. (MEDP)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
02 Nov 2026, 18:24:56 UTC
Prior SEC filing
01 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Stephen P. Ewald
Filing notes and source

Key filing fact

Stephen P. Ewald filed Form 4 for Medpace Holdings, Inc. (MEDP) on 02 Nov 2026.

Key facts

  • This page summarizes Stephen P. Ewald's Form 4 filing for Medpace Holdings, Inc. (MEDP).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Nov 2026, 18:24.

Change

  • Previous filing in this sequence was filed on 01 Jun 2026.
  • Current net transaction value: -$859,050.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001677297 Primary reporting owner

EWALD STEPHEN P

Relationship
General Counsel & Corp. Secy.
Address
C/O MEDPACE HOLDINGS,INC., 5375 MEDPACE WAY, CINCINNATI
Signature
/s/ Stephen P. Ewald
Signature date
02 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MEDP transaction

Common Stock

Sale

Transaction value
-$859,050
Shares
-1,245
Change %
-6.1%
Price
$690.00
Shares after
19,098
Date
29 Oct 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .